Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Boel
    Member
    • Oct 2009
    • 62

    #1

    Experience with ChIA-PET?

    Hi All,

    We are looking into ChIA-PET, a tool to look at genome wide chromatin interaction analysis. So far all publications seems to be from the group developing the procedure (PMID: 20181287 & 19890323). Does anyone out there have any experience with this technique, and any comments regarding the sensitivity and specificity, the pros and cons? Would be highly appreciated.

    Thanks,
    Boel
  • arendon
    Junior Member
    • Mar 2009
    • 6

    #2
    So are we. Should one interpret the lack of replies as CHIA-PET being really challenging?
    thx,
    augusto

    Comment

    • simonandrews
      Simon Andrews
      • May 2009
      • 870

      #3
      We've done a fair bit of work with this kind of data, and I'm currently writing tools for handling this kind of paired sequence data which will appear in a future version of SeqMonk.

      It's difficult to make general observations about this type of data as many of the problems we see are technical in nature and relate to the specific types of protocol being used (of which there are several related variants). I think it's fair to say that extracting biologically relevant information from these data is still very challenging, and it's pretty easy to draw incorrect conclusions by not accounting for factors which might introduce systematic bias in the frequency of interaction pairs you see. Also, if you're doing a comprehensive unbiased analysis then the volume of data is really problematic. Exponential increases in interactions from linear increases in measurement sites is no fun (well actually it is kind of fun in a masochistic way)!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...